发明名称 |
1-[2-(2,4-Dimethylphenylsulfanyl)-Phenyl]Piperazine As A Compound With Combined Serotonin Reuptake, 5-HT3 And 5-HT1a Activity For The Treatment Of Cognitive Impairment |
摘要 |
This disclosure relates to a method of treating a disease selected from the group consisting of affective disorders, depression, major depressive disorder, anxiety, general anxiety disorder, social anxiety disorder, obsessive compulsive disorder, panic disorder, and panic attacks. The method includes administering a therapeutically effective amount of Compound I or a pharmaceutically acceptable salt thereof to a patient in need thereof, in which Compound I is 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine. |
申请公布号 |
US2014377363(A1) |
申请公布日期 |
2014.12.25 |
申请号 |
US201414480949 |
申请日期 |
2014.09.09 |
申请人 |
H. Lundbeck A/S |
发明人 |
Bang-Andersen Benny;Mork Arne;Moore Nicholas;Stensbol Tine Bryan |
分类号 |
C07D295/096;A61K31/495;A61K9/14 |
主分类号 |
C07D295/096 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of treating a disease selected from the group consisting of affective disorders, depression, major depressive disorder, anxiety, general anxiety disorder, social anxiety disorder, obsessive compulsive disorder, panic disorder, and panic attacks, the method comprising administering a therapeutically effective amount of a pharmaceutically acceptable salt of Compound I to a patient in need thereof,
wherein the salt of Compound I is crystalline 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine hydrobromide salt characterized by XRPD reflections at 6.89, 9.73, 13.78 and 14.64+/−0.10° 2θ. |
地址 |
Valby-Coppenhagen DK |